Artificial intelligence (AI) is revolutionizing drug discovery by providing novel and efficient ways to identify potential therapeutic compounds. The process of discovering new drugs is […]
Why we should keep an eye on AI in Drug Discovery in 2023
Artificial intelligence (AI) is becoming an increasingly important tool in the field of drug discovery, with the potential to revolutionize the way new drugs are […]
Series B – Frontier Medicines
On Jul 19, 2021 Frontier Medicines closed a Series B round and raised $88,500,000 from ArrowMark Partners, DCVC Bio, Deep Track Capital, Deerfield, Driehaus Capital […]
Series C – Standigm
On Jul 6, 2021, Standigm closed a Series C round and raised $10,000,000 from lead investor Pavilion Capital. About the company: Standigm is located in […]
